- Investing Ideas
- Australian Healthcare Undervalued over 20% based on DCF
Australian Healthcare Undervalued over 20% based on DCF
Results
6
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
6 companies
Ramsay Health Care
Market Cap: AU$8.8b
Owns and operates hospitals in Australia and internationally.
RHC
AU$38.43
7D
5.6%
1Y
3.5%
Ansell
Market Cap: AU$4.0b
Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.
ANN
AU$28.96
7D
4.9%
1Y
-7.3%
PolyNovo
Market Cap: AU$718.5m
Designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong.
PNV
AU$1.04
7D
-3.3%
1Y
-20.3%
Cogstate
Market Cap: AU$476.1m
A neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide.
CGS
AU$2.79
7D
11.6%
1Y
123.2%
Alcidion Group
Market Cap: AU$137.7m
Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.
ALC
AU$0.10
7D
-2.4%
1Y
10.2%
SomnoMed
Market Cap: AU$127.1m
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.
SOM
AU$0.58
7D
-3.3%
1Y
-2.5%